A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Public ClinicalTrials.gov record NCT07213674. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Study identification
- NCT ID
- NCT07213674
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 750 participants
Conditions and interventions
Interventions
- Abiraterone acetate Drug
- Cabazitaxel Drug
- Docetaxel Drug
- Xaluritamig Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 27, 2025
- Primary completion
- Jan 6, 2030
- Completion
- Aug 29, 2032
- Last update posted
- Apr 23, 2026
2025 – 2032
United States locations
- U.S. sites
- 25
- U.S. states
- 18
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope Cancer Center Phoenix | Goodyear | Arizona | 85338 | Recruiting |
| City of Hope National Medical Center | Duarte | California | 91010 | Recruiting |
| City of Hope Orange County Lennar Foundation Cancer Center | Duarte | California | 91010 | Recruiting |
| Providence Saint Jude Medical Center | Fullerton | California | 92835 | Recruiting |
| Rocky Mountain Cancer Centers | Denver | Colorado | 80218 | Recruiting |
| Medical Oncology Hematology Consultants Helen F Graham Cancer Center | Newark | Delaware | 19713 | Recruiting |
| City of Hope Atlanta | Newnan | Georgia | 30265 | Recruiting |
| University of Illinois Chicago | Chicago | Illinois | 60612 | Recruiting |
| City of Hope Chicago | Zion | Illinois | 60099 | Recruiting |
| University of Kansas Medical Center | Westwood | Kansas | 66205 | Recruiting |
| Norton Cancer Institute | Louisville | Kentucky | 40207 | Recruiting |
| University of Maryland Greenebaum Cancer Center | Baltimore | Maryland | 21201 | Recruiting |
| Barbara Ann Karmanos Cancer Institute | Lansing | Michigan | 48910 | Recruiting |
| University of Minnesota Medical Center Fairview | Minneapolis | Minnesota | 55455 | Recruiting |
| Hematology Oncology Association of Central New York | East Syracuse | New York | 13057 | Recruiting |
| Oncology Hematology Care Incorporated | Cincinnati | Ohio | 45242 | Recruiting |
| Hightower Clinical | Oklahoma City | Oklahoma | 73102 | Recruiting |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15232 | Recruiting |
| United States Oncology Regulatory Affairs Corporate Office | Nashville | Tennessee | 37203 | Recruiting |
| The Center for Cancer and Blood Disorders | Arlington | Texas | 76012 | Recruiting |
| Texas Oncology Northeast Texas | Tyler | Texas | 75702 | Recruiting |
| US Oncology Research Investigational Products Center | Tyler | Texas | 75702 | Recruiting |
| University of Virginia Cancer Center | Charlottesville | Virginia | 22903 | Recruiting |
| Virginia Cancer Specialists PC | Leesburg | Virginia | 20176 | Recruiting |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 100 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07213674, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 23, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07213674 live on ClinicalTrials.gov.